DOCSLIB.ORG

D3.3 Map of Existing Digital Initiatives

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
D3.3 Map of Existing Digital Initiatives Ref. Ares(2018)1079046 - 26/02/2018 Smart 4 Europe Catalysing Digitisation throughout Europe Deliverable D3.3 Overview Map of Existing Digital Initiatives Grant Agreement number: 761.448 Project acronym: Smart 4 Europe Project title: Catalysing Digitisation throughout Europe Project co-ordinator name, title and organisation: Dr. Rainer Günzler, Hahn-Schickard Tel: +49 7721 943-188 Fax: +49 7721 943-210 E-mail: [email protected] Project website address: http://www.smart4europe.eu Responsible: THHINK Contributor(s): THK, HS, S2i Reviewer: HS Submission Date: M6 Due: M6 Nature1: R Dissemination level2: PU 1 R = Report, P = Prototype, D = Demonstrator, O = Other) 2 PU = Public, PP = Restricted to other programme participants (including the Commission Services), RE = Restricted to a group specified by the consortium (including the Commission Services), CO = Confidential, only for members of the consortium (including the Commission Services) Short description of the content of the deliverable The deliverable presents a map of existing digital initiatives. The various sources of national governmental support, Business Angel, and Private Equity funding that are available in each member state have been assessed. Based on this an overview map of relevant national and regional support for digital innovation has been created highlighting areas where certain types of funding are stronger or weaker along the innovation value chain. Version history Version Date Changes made by Sent to purpose 1.0 29.01.2018 Draft version THHINK Consortium Comment 1.1 26.02.2018 Issue 1 THHINK EC Issued 1.2 26.02.2018 Internal review HS 2.0 26.02.2018 submission Statement This deliverable is part of the achievement of the project Smart 4 Europe. The author is solely responsible for its content. The deliverable does not represent the opinion of the European Commission and the Commission is not responsible for any use that might be made of information or data appearing therein. The deliverable contains original, formerly unpublished work except where indicated by reference, quotation or by another appropriate acknowledgement. If parts of this document will be published before the submission and acceptance of the document as deliverable of the Smart 4 Europe project, they must be indicated as “preliminary results”. D 3.3 © Smart 4 Europe Consortium Page 2 Table of Contents 1. Executive Summary ....................................................................................................... 8 2. Introduction .................................................................................................................... 9 3. Types of Funding...........................................................................................................10 3.1 Research, Development and Innovation Funding................................................11 3.2 Business Angel Funding .....................................................................................11 3.3 Crowdfunding .....................................................................................................12 3.4 Venture Capital Funding .....................................................................................12 3.5 Analysis of Investment Support for Digitisation ...................................................14 4. Country by Country Analysis of Funding ........................................................................20 5. AT – Austria ..................................................................................................................23 5.1 Policy, Research and Innovation Initiatives .........................................................23 5.2 Business Angel Funding .....................................................................................23 5.3 Startup Funding ..................................................................................................24 5.4 Pre-Seed Funding ...............................................................................................25 5.5 Seed Funding .....................................................................................................26 5.6 Series A / Growth ................................................................................................26 5.7 Crowd Funding ...................................................................................................26 5.8 Venture Capital Funding .....................................................................................27 6. BE – Belgium ................................................................................................................28 6.1 Policy, Research and Innovation Initiatives .........................................................28 6.2 Business Angel Funding .....................................................................................28 6.3 Crowdfunding .....................................................................................................28 6.4 Venture Capital Funding .....................................................................................28 7. BG – Bulgaria ................................................................................................................30 7.1 Policy Research and Innovation Initiatives ..........................................................30 7.2 Business Angel Funding .....................................................................................30 7.3 Incubation ...........................................................................................................30 7.4 Venture Capital Funding .....................................................................................30 7.5 EIF Funding ........................................................................................................31 7.6 SME Initiative ......................................................................................................31 8. CY – Cyprus ..................................................................................................................32 8.1 Policy Research and Innovation Initiatives ..........................................................32 8.2 Business Angel Funding .....................................................................................32 8.3 Venture Capital Funding .....................................................................................32 D 3.3 © Smart 4 Europe Consortium Page 3 9. CZ - Czech Republic .....................................................................................................33 9.1 Policy, Research and Innovation Initiatives .........................................................33 9.2 Business Angel Funding .....................................................................................33 9.3 Venture Capital Funding .....................................................................................33 9.4 Czech ESIF Fund ...............................................................................................34 10. DE - Germany ............................................................................................................35 10.1 Policy, Research and Innovation Initiatives .........................................................35 10.2 Business Angel Funding .....................................................................................35 10.3 Company owned incubators and accelerators ....................................................36 10.4 National and international incubators and accelerators with seat in Berlin ..........36 10.5 Venture Capital Funding .....................................................................................37 11. DK – Denmark ...........................................................................................................39 11.1 Policy, Research and Innovation Initiatives .........................................................39 11.2 Business Angel Funding .....................................................................................39 11.3 Preseed ..............................................................................................................39 11.4 Accelerators ........................................................................................................39 11.5 Venture Capital Funding .....................................................................................40 12. EE – Estonia ..............................................................................................................41 12.1 Policy, Research and Innovation Initiatives .........................................................41 12.2 Business Angel Funding .....................................................................................41 12.3 Venture Capital Funding .....................................................................................41 12.4 EstFund ..............................................................................................................42 13. EL – Greece ..............................................................................................................43 13.1 Policy, Research and Innovation Initiatives .........................................................43 13.2 Business Angel Funding .....................................................................................43 13.3 Venture Capital Funding .....................................................................................43 14. ES - Spain .................................................................................................................45
Load more

Recommended publications
  • BIA Submission to the HMT Patient Capital Review.Pdf 0.85MB
    The BIA’s submission to the Patient Capital Review: Financing growth in innovative firms September 2017 About the BIA Established in 1989, the BioIndustry Association (BIA) is the UK trade association for innovative bioscience enterprises. BIA members include emerging and more established bioscience companies, pharmaceutical companies, academic research and philanthropic organisations, and service providers to the UK bioscience sector. Our members are responsible for over 90% of biotechnology-derived medicines currently in clinical development in the UK and are at the forefront of innovative scientific developments targeting areas of unmet medical need. This innovation leads to better outcomes for patients, to the development of the knowledge-based economy and to economic growth. Many of our members are small, pre-revenue companies operating at the translation interface between academia and commercialisation. Our goal is to secure the UK’s position as a global bioscience hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For additional information or clarification on any of the points raised please contact Dr Martin Turner, Policy and Projects Manager, on 0207 630 2192 or by emailing [email protected] BIA Consultation Response Page 2 Key points • The UK is globally recognized as a world leader in the life sciences. However, life science R&D is capital and time intensive, typically
    [Show full text]
  • Unaudited Financial Statements with Other Financial Information
    Unaudited Financial Statements With Other Financial Information West Virginia Board of Treasury Investments Consolidated Fund For the Month and Fiscal Year to Date Ended May 31, 2021 Fiscal Year is July 1, 2020 through June 30, 2021 (This page intentionally left blank.) West Virginia Board of Treasury Investments Consolidated Fund Unaudited Financial Statements with Other Financial Information For the Month and Fiscal Year to Date Ended May 31, 2021 Contents Unaudited Financial Statements: Unaudited Combining Statement of Fiduciary Net Position ................................................................. 2 Unaudited Combining Statement of Changes in Fiduciary Net Position ............................................... 4 Notes to Unaudited Financial Statements ............................................................................................... 9 Schedule of Investments in Securities ........................................................................................................ 18 Other Financial Information: Schedule of Net Asset Values .............................................................................................................. 34 Portfolio Statistics ................................................................................................................................ 35 Participant Net Asset Values ............................................................................................................... 36 Glossary of Financial and Investment Terms ......................................................................................
    [Show full text]
  • Map of Funding Sources for EU XR Technologies
    This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement N° 825545. XR4ALL (Grant Agreement 825545) “eXtended Reality for All” Coordination and Support Action D5.1: Map of funding sources for XR technologies Issued by: LucidWeb Issue date: 30/08/2019 Due date: 31/08/2019 Work Package Leader: Europe Unlimited Start date of project: 01 December 2018 Duration: 30 months Document History Version Date Changes 0.1 05/08/2019 First draft 0.2 26/08/2019 First version submitted for partners review 1.0 30/08/2019 Final version incorporating partners input Dissemination Level PU Public Restricted to other programme participants (including the EC PP Services) Restricted to a group specified by the consortium (including the EC RE Services) CO Confidential, only for members of the consortium (including the EC) This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement N° 825545. Main authors Name Organisation Leen Segers, Diana del Olmo LCWB Quality reviewers Name Organisation Youssef Sabbah, Tanja Baltus EUN Jacques Verly, Alain Gallez I3D LEGAL NOTICE The information and views set out in this report are those of the authors and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein. © XR4ALL Consortium, 2019 Reproduction is authorised provided the source is acknowledged. D5.1 Map of funding sources for XR technologies - 30/08/2019 Page 1 Table of Contents INTRODUCTION ................................................................................................................
    [Show full text]
  • Future Finance & Investment Chapter
    FUTURE FINANCE & INVESTMENT CHAPTER MEMBERS FUTURE FINANCE & INVESTMENT CHAPTER MEMBERS OF THE GRI GLOBAL COMMITTEE FUTURE FINANCE & INVESTMENT CHAIRPERSON VICE-CHAIR Audrey Klein Peter Plaut Head of Investor Relations (Funds) Executive Director Kennedy Wilson Wimmer Family Office Investor Relations (Funds) Investor - Family Office Kennedy Wilson is a global real estate operator. We focus Wimmer Family Office offers both bespoke investment portfolio on multifamily, office and industrial properties located in the solutions for family offices and high net worth individuals as Western U.S., U.K., Ireland and Spain. Headquartered in Beverly well as its core investment trend following strategy through the Wimmer Wealth Protection Fund. Hills, CA, and London, UK, Kennedy Wilson has 16 global offices. Audrey Klein is the Head of Fundraising for Kennedy Wilson Europe. Prior to Peter Plaut is an Executive Director at Wimmer Family Office focused on origination, this she held Head of Fundraising roles at several firms but is best known for researching and structuring private debt and equity transactions across a broad range starting the European business out of London for the Park Hill Real Estate of industries including specializing in real estate across the residential, office and hotel Group, a Division of Blackstone, which she ran for 9 yrs. Prior to joining Park and hospitality sectors. Minimum transaction size is $100mm to well over $1 billion. Hill, she ran her own business for 5 yrs marketing alternative asset funds Mr. Plaut is consistently recognized as a leader in the industry. Among his many across all asset classes including private equity, real estate and hedge funds achievements and awards, he was ranked as one of the Top 20 Rising Stars of Hedge to European investors comprised of pension funds, banks, family offices and Funds during the 2008 financial crisis –a recognition of his ability to manage through high net worth individuals.
    [Show full text]
  • Diversity in UK Venture Capital 2019 2
    A report by Diversity VC Sponsored by Silicon Valley Bank Published July 2019 Diversity in UK Venture Capital 2019 2 With thanks to our Research Team Executive Team Diversity Research Team 2019 Diversity VC Team Travis Winstanley Diane Albouy David Kelnar Shriya Anand Research Lead, Co-founder, Diversity VC Balderton Capital MMC Ventures Bain & Company Catalis Group Meriwether Beckwith Dan Mackie Seb Butt Lillian Li Oxford Capital Craft.co Co-founder, Diversity VC Kirsty MacDonald Eight Roads Ventures Victoria Bernath JamJar Investments Juliet Bailin University of York Mosaic Ventures Francesca Warner, CEO Patricia Nicola Co-founder, Diversity VC James Downing Seedrs Ben Goldsmith Diversity VC Silicon Valley Bank Goldsmith Communications Shane Porter Bain & Company Sarah Millar Blake Falk Citylight Capital Bain & Company Magda Posluszny Speed Invest Esther Delignant Rodriguez Christina Franzeskides Oxford Capital Entrepreneur First (LD12) Lucy Rands ETF Partners Tong Gu Michael Tefula Downing Ventures Accelerated Digital Ventures Abhi Setia London School of Economics Belinda Gurung Farooq Abbasi Constanoa Ventures JamJar Investments Shrenik Sanghrajka Bain & Company Harry Hamer London Venture Partners Imran Tehal DN Capital Julie Kainz Salesforce Ventures Ella Wales Bonner JamJar Investments Full list of contributors is available in the Appendix. Diversity in UK Venture Capital 2019 3 Contents Foreword 5 Introduction 6 Key Findings 10 Gender 12 Education 17 Career 21 Ethnicity 24 Discussion 26 Conclusion 36 About Diversity VC 40 Appendix 42 References 42 Our Contributors 42 Our Sponsor 46 Our Partners and Collaborators 47 Our Methodology 48 Firms in our analysis 52 Diversity in UK Venture Capital 2019 4 Launch of Women in UK Venture Capital (2017) Source: Diversity VC Diversity in UK Venture Capital 2019 Introduction Foreword 5 A warm welcome to ‘Diversity in UK Venture Capital 2019’.
    [Show full text]
  • Equity Crowdfunding: All Regulated but Not Equal
    DePaul Business and Commercial Law Journal Volume 13 Issue 3 Spring 2015 Article 2 Equity Crowdfunding: All Regulated but Not Equal Garry A. Gabison Follow this and additional works at: https://via.library.depaul.edu/bclj Recommended Citation Garry A. Gabison, Equity Crowdfunding: All Regulated but Not Equal, 13 DePaul Bus. & Com. L.J. 359 (2015) Available at: https://via.library.depaul.edu/bclj/vol13/iss3/2 This Article is brought to you for free and open access by the College of Law at Via Sapientiae. It has been accepted for inclusion in DePaul Business and Commercial Law Journal by an authorized editor of Via Sapientiae. For more information, please contact [email protected]. Equity Crowdfunding: All Regulated but Not Equal Garry A. Gabison* This Article describes how different countries have approached eq- uity crowdfunding. It focuses on countries or regulatory authorities that either expressed their awareness of the phenomenon but decided to adopt a holding pattern (monitoring and investigating) or new laws and regulations. Countries like Australia have opted to reaffirm how their current set of regulations applies to crowdfunding whereas others like the United States, Italy, the United Kingdom, and France have elected to create new exemptions in an effort to facilitate equity crowdfunding. This Article compares how each country decided to regulate the different participantsin the crowdfunding process. While the results of these various efforts are still mostly unseen, this Article takes an early look at the regulatory impact using one U.K. based platform as an example of how regulations can boost investment. CONTENTS I. INTRODUCTION ...........................................
    [Show full text]
  • Crowdfunding Monitor Switzerland 2021
    Institute of Financial Services Zug IFZ Crowdfunding Monitor Switzerland 2021 hslu.ch/crowdfunding Prof Dr Andreas Dietrich, Dr. Simon Amrein We are grateful to the following platforms for supporting this study by providing data: Summary of key results In 2020 CHF 606.6 million (+2%) was raised in Switzerland. CHF 2.29 billion has been raised through crowdfunding since the launch of the first crowd- funding platform in Switzerland thirteen years ago. The highest growth from 2019 to 2020 was posted by reward-based crowdfunding / crowddonating (+82%, to CHF 44.6 million). Crowdlending posted growth (+7%, to CHF 448 m), but crowdinvesting declined in value compared to 2019 (-26%, to CHF 114 m). Some 270,000 people backed crowdfunding projects in Switzerland in 2020. 38 crowdfunding platforms were operating in Switzerland at the end of April 2021 (domiciled in Switzerland). That said, 2020 saw active funding campaigns recorded on only 28 Swiss platforms. Foreword Crowdfunding Monitor 2021 Foreword Crowdfunding is a means of raising finance via online platforms for a wide variety of projects. These can include loans for companies, participating in a business start-up, co-acquiring a property or fi- nancing social projects. Crowdfunding projects thus cover a range of areas. Nevertheless, they all have one thing in common: typically, a large number of people provide an amount that is often small, enabling the project to be realised. Direct, internet-based communication between those providing funds and those seeking funds is a key element of all types of crowdfunding. 38 active platforms are currently operating in Switzerland. The volumes reported by these crowdfund- ing platforms have again exhibited a positive trend in 2020: 2020 saw some CHF 607 million raised.
    [Show full text]
  • Gimv Invests in Biopharmaceutical Company Complix
    Antwerp, 26 June 2013, 7:30 AM CET Gimv invests in biopharmaceutical company Complix Gimv and Gimv managed Biotech Fonds Vlaanderen invest in Complix, a biopharmaceutical company focused on the discovery and development of novel therapeutics based on its AlphabodiesTM platform. This investment is part of a total Series B equity financing round of EUR 12 million from a syndicate of important life sciences investors, co-led by new investors Gimv and Edmond de Rothschild Investment Partners. Complix is a biopharmaceutical company developing a pipeline of therapeutics, called AlphabodiesTM, mainly focused on oncology and autoimmunity. Alphabodies are a revolutionary class of protein therapeutics that combine the attractive features of antibodies, including high target specificity and affinity, with the benefits from small chemical drugs such as extreme stability and their capacity to penetrate cells. As a result of these unique features, Alphabodies can tackle a broad range of diseases where treatment options today are limited or non-existent. Complix is headquartered in Hasselt (Belgium) at the Life Sciences incubator BioVille, and has research facilities in Ghent (Belgium) and in Luxembourg. Since its founding in 2008 Complix has raised a total of EUR 26 million in funding, including the EUR 12 million capital round announced today. This financing round will be used to develop a first set of therapeutic Alphabodies for treatment of cancer and auto- immune indications, and to further develop and validate the company’s unique Alphabody platform. Mr Patrick Van Beneden, Partner at Gimv, comments: “We are very excited by the Complix opportunity because it perfectly fits in our Health & Care platform strategy for biotech investments.
    [Show full text]
  • Annual Report 2018 - 2019
    ANNUAL REPORT 2018 - 2019 ANNUAL REPORT 2018 - 2019 LEADING OUR PORTFOLIO COMPANIES FOR THE BENEFIT OF OUR ECONOMY. CONTENTS 1. Message from Chairman and CEO 5 2. Business model and investment strategy 9 3. Value creation starting from 4 central themes 23 4. Results and activity report 35 5. Key figures 41 6. Share and shareholders 45 7. Corporate Governance Statement 49 8. Annual Accounts 77 9. Contact 141 INVESTMENT PORTFOLIO EUR 1.1 BILLION OUR 55 PORTFOLIO COMPANIES JOINTLY REALISE A TURNOVER OF MORE THAN EUR 2.75 BILLION AND EMPLOY 14 000 PROFESSIONALS FOCUS ON VALUE CREATION FROM 4 PLATFORMS CONNECTED HEALTH SMART SUSTAINABLE CONSUMER & CARE INDUSTRIES CITIES 4 OFFICES WITH MULTIDISCIPLINARY TEAMS: ANTWERP, PARIS, THE HAGUE, MUNICH 39 YEARS’ EXPERIENCE IN PRIVATE EQUITY OVER THE LAST 5 YEARS INVESTED IN 932 EUR MILLION 46 COMPANIES PROCEEDS FROM 1 520 EUR MILLION 48 EXITS MESSAGE FROM CHAIRMAN AND CEO1 6 ANNUAL REPORT 2018-2019 The world around us is changing at an incredible pace. Last year we were still talk- ing about an improving economy that had moved up several gears; today, barely a year later, we see this economic upswing under threat from various geopolitical and macroeconomic factors. Trade relations are more difficult, the power posi- IMPACT: MEETING CRUCIAL tions and therefore also the relationships between CHALLENGES TOGETHER the major world economic powers are shifting, as evidenced by the never-ending story of Brexit. Gimv goes looking for the market leaders of Last year, climate and the environment concerns tomorrow, together with which it can make a vi- topped the political and economic agenda, calling tal difference, year after year.
    [Show full text]
  • Preqin Industry News Download Data
    View the full edition of Spotlight at: https://www.preqin.com/docs/newsletters/pe/Preqin-Private-Equity-Spotlight-July-2014.pdf News Preqin Industry News Download Data Preqin Industry News Joel Coulson and Chloe Wong take a look at the European venture capital market, including Europe-focused venture capital funds that have recently launched or held a final close, as well as prominent venture capital deals in the region. Several notable European venture capital financings were announced recently: How has venture capital deal activity changed in recent years? In June 2014, Kobalt Music Group Ltd, a global music publisher and music services company that offers administrative and Chart of the Month: Number and Value of Venture creative expertise, raised $115mn funding, of a $140mn round, Capital Deals in Europe, Q1 2007 - Q2 2014 from returning investor Balderton Capital and other unspecifi ed investors. MSD Capital committed $25mn of the $140mn funding 500 3.0 round in February 2014, via primary investment and also the 450 (€bn) Aggregate Deal Value acquisition of a stake from SPARK Ventures, which sold its last 2.5 400 remaining shares in the company. 350 2.0 Elasticsearch, a Dutch open source search engine, added $70mn 300 funding in June 2014 to its $34mn prior funding having raised series 250 1.5 A and series B rounds from Benchmark Capital, Data Collective, 200 No. of Deals 1.0 Index Ventures and SV Angel in November 2012 and February 150 2013. The recent series C round was led by new investor New 100 Enterprise Associates with participation from returning investors 0.5 50 Benchmark Capital and Index Ventures.
    [Show full text]
  • RI Transparency Report Is One of the Key Outputs of This Framework
    RI TRANSPARENCY REPO RT 2019 Idinvest Partners An investor initiative in partnership with UNEP Finance Initiative and UN Global Compact About this report The PRI Reporting Framework is a key step in the journey towards building a common language and industry standard for reporting responsible investment (RI) activities. This RI Transparency Report is one of the key outputs of this Framework. Its primary objective is to enable signatory transparency on RI activities and facilitate dialogue between investors and their clients, beneficiaries and other stakeholders. A copy of this report will be publicly disclosed for all reporting signatories on the PRI website, ensuring accountability of the PRI Initiative and its signatories. This report is an export of the individual Signatory organisation’s response to the PRI during the reporting period specified above. It includes their responses to mandatory indicators, as well as responses to voluntary indicators the signatory has agreed to make public. The information is presented exactly as it was reported. Where an indicator offers a response option that is multiple-choice, all options that were available to the signatory to select are presented in this report. Presenting the information exactly as reported is a result of signatory feedback which suggested the PRI not summarise the information. PRI disclaimer This document presents information reported directly by signatories. This information has not been audited by the PRI Secretariat or any other party acting on their behalf. While this information is believed to be reliable, no representations or warranties are made as to the accuracy of the information presented, and no responsibility or liability can be accepted for any error or omission.
    [Show full text]
  • Entrepreneurship in Spain
    All you need to know about entrepreneurship in Spain June 2021 edition A way to make Europe EUROPEAN REGIONAL DEVELOPMENT1 FUND CONTENT Part I – STARTING POINT • Creating a startup Part II – RESOURCES FOR STARTUPS • Resources for startups • Incubators • Accelerators • Specific services suppliers Part III – FINANCING FOR STARTUPS • How to obtain financing • Private sector • Public sector • European calls • National calls Part IV – EVENTS FOR STARTUPS • Events Part V – AUTONOMOUS REGIONS • Programs and subsidies for startups This guide is intended as a collection of resources for startups in their different stages of seeking public and/or private funding 2 Part I Starting point CREATING A STARTUP IN SPAIN The steps to establish a startup are the same as for any other company. The very first one is to determine the most appropriate legal form, a decision that will be influenced by the startup´s later needs regarding participation deals and receipt of third-party investment. The most used legal forms are: Spain • Limited Liability Company (Sociedad Limitada, S.L.) in • Corporation (Sociedad Anónima, S.A.). startup Both forms can also be set up as a sole-shareholder entity (Sociedad Anónima Unipersonal, S.A.U. and Sociedad Limitada Unipersonal, S.L.U. respectively) a at the time of incorporation or be converted into a sole-shareholder entity afterwards. While there are alternatives to these legal forms, they aren´t advisable for startups that will be seeking to add partners to the project and/or third-party investors. For information purposes, these include: Freelancer (Autónomo), Private partnership (Sociedad Civil) or Jointly-Owned Entity (Comunidad de creating Bienes), or a Cooperative (Cooperativa).
    [Show full text]